Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?
about
Compliance of disease awareness campaigns in printed Dutch media with national and international regulatory guidelinesPrescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug AdministrationDirect-to-Consumer Promotion of Prescription Drugs on Mobile Devices: Content AnalysisMefenamic Acid induced nephrotoxicity: an animal modelThe effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysisUnderstanding Health Information Seeking from an Actor-Centric PerspectiveDirect-to-consumer Marketing to People with HemophiliaThe Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin useEffect of Direct-to-Consumer Advertising on Statin Use in the United States.Mixed Messages, Mixed Outcomes: Exposure to Direct-to-Consumer Advertising for Statin Drugs is Associated with More Frequent Visits to Fast Food Restaurants and Exercise.How Did Erectile Dysfunction Become "Natural"? A Review of the Critical Social Scientific Literature on Medical Treatment for Male Sexual Dysfunction.Direct-to-Consumer Advertising: Implications for the Pharmacist and Other Health Professionals.Then and Now: Examining How Consumer Communication and Attitudes of Direct-to-Consumer Pharmaceutical Advertising Have Changed in the Last Decade.Feeling Is Believing: Evaluative Conditioning and the Ethics of Pharmaceutical Advertising.Do Prescription Drug Ads Tell Consumers Enough About Benefits and Side Effects? Results From the Health Information National Trends Survey, Fourth Administration.Direct to consumer advertising: the case for greater consumer controlPublic attitudes towards psychiatric medication: a comparison between United States and Germany.Disease Information in Direct-to-Consumer Prescription Drug Print Ads.Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study.Don't ban the sunset in pharmaceutical advertising if it doesn't darken the sky."When diet and exercise are not enough": an examination of lifestyle change inefficacy claims in direct-to-consumer advertising.If health care advertising is a problem, FDA-style regulation is not the solution.Testimonials and Informational Videos on Branded Prescription Drug Websites: Experimental Study to Assess Influence on Consumer Knowledge and Perceptions.Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.Impact of a direct-to-consumer information campaign on prescription patterns for overactive bladder.
P2860
Q28542862-032B71B4-EA22-4F0F-9D44-3F41E5033019Q28551840-85CD14BE-D2F3-44AC-99D4-8B854C960C5AQ33455406-A5685D62-5233-44AA-A376-080BC474C6EDQ34063879-0D5A71C3-446F-47DE-BE2B-46ABCFF7A495Q35210066-F395D4E5-1768-476D-B3A3-38A0FD20201BQ35891030-A71FC2E4-4184-4861-B8C1-446621F11CC0Q36051468-6E21CB8D-A1BD-4B2E-86B0-F188D20ED7E9Q36854337-A7EE7591-B5AD-4494-B8DE-649702CDFBD7Q36927407-D84F3767-4D8D-41FB-A14B-355F4178948CQ38734098-E8D62EAA-ED1E-4A70-93F3-922703ECDF93Q38840755-B07A3967-EF7F-41BC-B074-788BFC944225Q39036492-13AB4A12-5159-4BD0-AFE6-E0E1492493F0Q39199293-B25FD022-0FDF-4EC3-8079-9E22B26A7193Q39315585-D356B862-C8E3-41C4-A648-B2CD183E21B0Q40052369-0B168FDD-D01F-4A57-A444-6332B7B03B89Q40786904-C412BC64-C013-4E83-9C88-A37F63DDD12BQ42022892-2AE70922-A582-4956-A8E9-B1DD936BCE15Q42973999-96B789D6-17B9-4CC2-BA20-F7F6B7B47521Q44338468-188063BA-6749-4B26-A07C-152BE3705B9EQ44338946-1EA34F7F-8D24-416A-825E-303C5D77B0D1Q44659268-1E0C11DB-0948-43B4-B2A0-FF8366EAD761Q44808297-95B285C6-6B11-484E-AD7B-6F2E6727FC5DQ48084158-7159833A-183F-48CD-9973-124F72EFF50FQ48181710-E4249B37-B371-4AB8-97EE-EF59844054A2Q51747127-DE9115D1-21F7-45D0-A17E-F63505DC4061Q55195470-BEB5BED4-8841-4FFE-9887-5C490504CF5D
P2860
Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advertising of prescription-on ...... f benefit counterbalance harm?
@en
Advertising of prescription-on ...... f benefit counterbalance harm?
@nl
type
label
Advertising of prescription-on ...... f benefit counterbalance harm?
@en
Advertising of prescription-on ...... f benefit counterbalance harm?
@nl
prefLabel
Advertising of prescription-on ...... f benefit counterbalance harm?
@en
Advertising of prescription-on ...... f benefit counterbalance harm?
@nl
P1476
Advertising of prescription-on ...... f benefit counterbalance harm?
@en
P2093
Barbara Mintzes
P304
P356
10.1146/ANNUREV-PUBLHEALTH-031811-124540
P577
2012-04-01T00:00:00Z